2010
DOI: 10.1097/mph.0b013e3181c9af65
|View full text |Cite
|
Sign up to set email alerts
|

t(12:21) is Underrepresented in Childhood B-lineage Acute Lymphoblastic Leukemia in Punjab, Pakistan

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2014
2014
2016
2016

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(3 citation statements)
references
References 13 publications
0
3
0
Order By: Relevance
“…Previously, the prevalence of TEL-AML1 fusion oncogene in Pakistani population has been reported by to be 11% (Iqbal and Tanveer, 2006) which is in accordance with our findings, although that study lacked clinical outcome of TEL-AML1 positive patients. In another study from Lahore, Punjab, Pakistan, 6% (3/50) frequency of TEL-AML1 has been reported (Faiz and Qazi., 2010), while others have reported frequency of this gene to be to be about 16% (Iqbal et al, 2007;Awan et al, 2012). However, all of these studies were carried out at single centre or locations in Pakistan and does not represent a major subset of childhood ALL population of the country.…”
Section: Discussionmentioning
confidence: 96%
See 1 more Smart Citation
“…Previously, the prevalence of TEL-AML1 fusion oncogene in Pakistani population has been reported by to be 11% (Iqbal and Tanveer, 2006) which is in accordance with our findings, although that study lacked clinical outcome of TEL-AML1 positive patients. In another study from Lahore, Punjab, Pakistan, 6% (3/50) frequency of TEL-AML1 has been reported (Faiz and Qazi., 2010), while others have reported frequency of this gene to be to be about 16% (Iqbal et al, 2007;Awan et al, 2012). However, all of these studies were carried out at single centre or locations in Pakistan and does not represent a major subset of childhood ALL population of the country.…”
Section: Discussionmentioning
confidence: 96%
“…Although, global frequency of TEL-AML1 positivity has been reported to be 20-30% in pediatric ALL (Hong et al, 2008), some authors have reported very lower frequencies of TEL-AML1in some geographical regions (Kwong and Wong, 1997;Eguchi-Ishimae et al, 1998;Garcia-Sanz et al, 1999;Tsang et al, 2001;Rahman et al, 2006;Chung et al, 2010;Mazloumi et al, 2012) including one study from a single centre at Lahore, Punjab, Pakistan indicating 6% (3/50) frequency of TEL-AML1 (Faiz and Qazi, 2010), while others have reported frequency of this gene to be at other single Centres to be about 16% (Iqbal et al, 2007;Sabir et al, 2012). However, all of these studies were carried out at single centre or locations in Pakistan and therefore does not provide a comprehensive view of TEL-AML1 frequency in Pakistani population.…”
Section: Molecular Genetic Studies On 167 Pediatric All Patients Frommentioning
confidence: 99%
“…Faiz and Qazi also reported a less than expected favourable translocation t (12; 21) in Pakistani population. [18,19] However, even the highest estimates place the adverse cytogenetics group around 7-8%, which would still mean that over 90% of children could possibly be stratified to receive a lower intensity treatment. The importance of risk stratification is thus highlighted based on conventional, molecular and cytogenetic criteria to avoid over or under treatment.…”
Section: Discussionmentioning
confidence: 99%